These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3087182)

  • 1. Positron emission tomographic study of D2 dopamine receptor binding and CSF biogenic amine metabolites in Rett syndrome.
    Harris JC; Wong DF; Wagner HN; Rett A; Naidu S; Dannals RF; Links JM; Batshaw ML; Moser HW
    Am J Med Genet Suppl; 1986; 1():201-10. PubMed ID: 3087182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rett syndrome: positron emission tomography (PET) studies.
    Wagner HN
    Am J Med Genet Suppl; 1986; 1():211-24. PubMed ID: 3087184
    [No Abstract]   [Full Text] [Related]  

  • 3. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor.
    Welch MJ; Katzenellenbogen JA; Mathias CJ; Brodack JW; Carlson KE; Chi DY; Dence CS; Kilbourn MR; Perlmutter JS; Raichle ME
    Int J Rad Appl Instrum B; 1988; 15(1):83-97. PubMed ID: 3258305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography.
    Satyamurthy N; Bida GT; Barrio JR; Luxen A; Mazziotta JC; Huang SC; Phelps ME
    Int J Rad Appl Instrum B; 1986; 13(6):617-24. PubMed ID: 3494003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging dopamine receptors in the human brain by positron tomography.
    Wagner HN; Burns HD; Dannals RF; Wong DF; Langstrom B; Duelfer T; Frost JJ; Ravert HT; Links JM; Rosenbloom SB; Lukas SE; Kramer AV; Kuhar MJ
    Science; 1983 Sep; 221(4617):1264-6. PubMed ID: 6604315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
    Wong DF; Wagner HN; Tune LE; Dannals RF; Pearlson GD; Links JM; Tamminga CA; Broussolle EP; Ravert HT; Wilson AA; Toung JK; Malat J; Williams JA; O'Tuama LA; Snyder SH; Kuhar MJ; Gjedde A
    Science; 1986 Dec; 234(4783):1558-63. PubMed ID: 2878495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.
    Arnett CD; Wolf AP; Shiue CY; Fowler JS; MacGregor RR; Christman DR; Smith MR
    J Nucl Med; 1986 Dec; 27(12):1878-82. PubMed ID: 3491193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
    Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2-like dopamine receptor density in Tourette syndrome measured by PET.
    Wong DF; Singer HS; Brandt J; Shaya E; Chen C; Brown J; Kimball AW; Gjedde A; Dannals RF; Ravert HT; Wilson PD; Wagner HN
    J Nucl Med; 1997 Aug; 38(8):1243-7. PubMed ID: 9255158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone.
    Hägglund J; Aquilonius SM; Eckernäs SA; Hartvig P; Lundquist H; Gullberg P; Långström B
    Acta Neurol Scand; 1987 Feb; 75(2):87-94. PubMed ID: 2953165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of unilateral perinatal hypoxic-ischemic brain injury in the rat on dopamine D1 and D2 receptors and uptake sites: a quantitative autoradiographic study.
    Przedborski S; Kostic V; Jackson-Lewis V; Cadet JL; Burke RE
    J Neurochem; 1991 Dec; 57(6):1951-61. PubMed ID: 1834800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors.
    Mach RH; Jackson JR; Luedtke RR; Ivins KJ; Molinoff PB; Ehrenkaufer RL
    J Med Chem; 1992 Feb; 35(3):423-30. PubMed ID: 1531364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor binding and selectivity of three 11C-labelled dopamine receptor antagonists in the brain of rhesus monkeys studied with positron emission tomography.
    Hartvig P; Eckernäs SA; Ekblom B; Lindström L; Lundqvist H; Axelsson S; Fasth KJ; Gullberg P; Långström B
    Acta Neurol Scand; 1988 Apr; 77(4):314-21. PubMed ID: 3260438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative movement disorders: the contribution of functional imaging.
    Piccini P
    Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.
    Pearlson GD; Wong DF; Tune LE; Ross CA; Chase GA; Links JM; Dannals RF; Wilson AA; Ravert HT; Wagner HN
    Arch Gen Psychiatry; 1995 Jun; 52(6):471-7. PubMed ID: 7771917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography.
    Leenders KL; Frackowiak RS; Quinn N; Marsden CD
    Mov Disord; 1986; 1(1):69-77. PubMed ID: 2973559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.